John Gillen | Founder | European Pioneer of NAD+
Mr. John Gillen
European Pioneer of NAD+
Founder | John Gillen
For over a decade, he has travelled the world to obtain answers. This led to the realisation that the co-enzyme NAD+ (Nicotinamide adenine dinucleotide) was the central metabolite required for cell function. John explains it quite simply as being the “miracle molecule”, finding scientific evidence for this cellular fuel and realising the potential for numerous conditions with NAD+ as the vital component for regenerative medicine.” NADCELL now offers NAD+ intravenous therapy. John was the first pioneer to bring NAD+ treatment to Europe in 2013. His passion extends to other metabolic disturbances and neurodegenerative diseases.
The journey continues; in recent times, John has travelled to Russia to study and research a new therapy known as photobiomudulation, or intravenous laser and ultra violet therapy, working with scientists and the very best of medical professionals in the UK. Together with Nadcell Clinic’s own select doctors, nurses, dieticians and therapists, John’s passion continues to bring to the UK new ways of helping clients with restorative medicine and wellness. In 2017, John Gillen became a visiting professor at the John Naisbitt university in Belgrade, Serbia.